Suicide rates in the lundby cohort before and after the introduction of tricyclic antidepressant drugs

Archives of Suicide Research

Volumn 11, Issue 1, 2007, Pages 57-67

  Nettelbladt, Per ^a   Mattisson, Cecilia ^a   Bogren, Mats ^a   Holmqvist, Marika ^b  

^a LUND UNIVERSITY   (Sweden)

^b Centre of Surgery and Oncology   (Sweden)

Author keywords

Cohort study; Incidence study; Longitudinal study; Suicides; The Lundby study; Tricyclic antidepressant drugs (TCAs)

Indexed keywords

TRICYCLIC ANTIDEPRESSANT AGENT;

ADOLESCENT; ADULT; AGED; ALCOHOLISM; ARTICLE; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DEPRESSION; FEMALE; HUMAN; INCIDENCE; LONGITUDINAL STUDY; MALE; MENTAL DISEASE; MIDDLE AGED; MORTALITY; STATISTICS; SUICIDE; SWEDEN;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALCOHOLISM; ANTIDEPRESSIVE AGENTS, TRICYCLIC; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER; FEMALE; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MENTAL DISORDERS; MIDDLE AGED; SUICIDE; SWEDEN;

EID: 33845784194     PISSN: 13811118     EISSN: 15436136     Source Type: Journal    
DOI: 10.1080/13811110600992886     Document Type: Article

References (32)

1. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders, 4th ed. (DSM-IV), Washington, DC: American Psychiatric Association.
2. Angst, F., Stassen, H. H., Clayton, P. J., et al. (2002). Mortality of patients with mood disorders: follow-up over 34-38 years. J. Afffect. Disord., 68(2-3), 167-181.
3. Apoteket AB. (2006). http.//www.apoteket.se.
4. Beasley, C. M. Jr., Dornseif, B. E., Bosomworth, J. C., et al. (1991). Fluoxetine and suicide: a meta.analysis of contrrolled trials of treatment for depression. British Medical Journal, 303, 685-92.
5. Bertolte, J. M. J., Fleischmann, A., De Leo, D., et al. (2004). Psychiatric diagnosis and suicide: revisiting the evidence. Crisis, 25(4), 147-55.
6. Cerletti, U. (1940) L'elettroschock. Le alterazioni istopatologische del sistema nervoso in sequito all'E.S. Riv. Spe. Freniatr. Ecc., 64.
7. Clayton, D. & Hills, M. (1993). Statistical models in epidemiology. New York: Oxford University Press Inc.
8. Essen-Möller, E., Larsson, H., Uddenberg, C.-E., et al. (1956). Individual Traits and morbidity in a Swedish rural population. Acta Psychiat et Neurolog Scand, Suppl 100.
9. Grunebaum, M. F., Ellis, S. P., Li, S., et al. (2004). Antidepressants and suicide risk in the United states, 1985-1999. J Clin Psychiatry, 65(11), 1456-62.
10. Gunnell, D. & Ashby, D. (2004). Antidepressants and suicide: what is the balance of benefit and harm. British Medical Journal, 329, 34-8.
11. Hagnell, O., Essen-Möller, E., Lanke, J., et al. (1990). The Incidence of mental illness over a quarter of a century. Stockholm: Almqvist & Wiksell.
12. Hagnell, O., Lanke, J., & Rorsman, B. (1981). Suicide rates in the Lundby Study: Mental illness as a risk factor for suicide. Neuropsychobiology, 7, 284-253.
13. Hagnell, O., Lanke, J., & Rorsman, B. (1982). Suicide and depression in the male part of the Lundby Study. Changes over time during a 25-year observation period. Neuropsychobiology, 8, 182-187.
14. Harris, E. C. & Barraclough, B. (1997). Suicide as an outcome for mental disorders. A meta-analysis. Brit J Psychiatry, 170, 205-228.
15. Isacsson, G. (2000) Suicide prevention - a medical breakthrough? Acta Psychiatr Scand, 102(2), 113-7.
16. Isometsa, E., Heikkinen, M., Henriksson, M., et al. (1995). Recent life events and completed suicide in bipolar affective disorder. A comparison with major depressive suicides. J Affect Dis, 33, 99-106.
17. Kaplan, H. I., Sadock, B. J., Grebb, J. A. (1994). Synopsis of psychiatry: Behavioral sciences, clinical psychiatry. Baltimore: Williams and Wilkins.
18. Khan, A., Khan, S., Kolts, R., et al. (2003).Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: Analysis of FDA reports. Am J Psychiatry, Apr., 160(4):790-2.
19. Läkemedelsverket. (2006). http://www.lakemedelsverket.se.
20. Leighton, D. C., Harding, D. C., Macklin, D. B., et al. (1963). The character of danger. The Stirling County Study. New York: Basic Books.
21. Loomer, H. P., Saunders, J. C., & Kline, N. S. (1957). A clinical and pharmacodynamic evaluation of iproniazid as psychic energizer. Psychiatr Res Rep Am Psychiatr Assoc 1957, 8, 129-41.
22. Mortensen, P. B., Agerbo, E., Erikson, T., et al. (2000). Psychiatric illness and risk factors for suicide in Denmark. The Lancet, 335, 9-12.
23. Nettelbladt, P., Bogren. M., Mattisson, C., et al. (2005). Does it make sense to do repeated surveys? - The Lundby Study 1947-1997. Acta Psychiatr Scand, 111, 444-452.
24. Öjesjö, L, Hagnell, O., Lanke, J. (1983). Class variations in the incidence of alcoholism in the Lundby Study, Sweden. Soc Psychiatry, 18, 123-128.
25. Rothman, K. J. & Greenland, S. (1998). Modern epidemiology, 2nd ed. Philadelphia: Lipincott Williams & Wilkins, p. 126.
26. Schou, M. (2001). Lithium treatment at 52. J Affect Disorder, Dec, 67(1-3), 21-32.
27. Shah, R., Uren, Z., Baker, A., et al. (2001). Deaths from antidepressants in England and Wales 1993-1997: Analysis of a new database. Psychol Med, 31, 1203-10.
28. Swedish Central Bureau of Statistics. (1911-1993). Statistics Sweden. Stockholm.
29. The National Board of Health and Welfare. (2004a). The cause of death register. Stockholm.
30. The National Board of Health and Welfare. (2004b). The patient register. Stockholm.
31. World Health Organization. (1965). International classification of diseases, injuries and causes of death, 8th Rev. ICD-8. Geneva.
32. World Health Organization. (1985). International classification of diseases, injuries and causes of death, 9th Rev. ICD-9. Geneva.